Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This is multicenter, randomised, placebo controlled, parallel, double blinded , superiority
clinical study comparing ozenoxacin cream versus placebo, in patients with a clinical
diagnosis of non-bullous or bullous impetigo.